Authors
Loading...
This proof-of-principle study demonstrates a new liquid biopsy workflow that isolates and profiles CTCs in myeloma, highlighting its potential for better disease monitoring.
Shifrin et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: